May 17, 2022
Article
The importance of addressing disorders of the brain cannot be overstated, and doing so will be essential to our generation and generations to come.
February 18, 2022
Video
The director of Cleveland Clinic’s Epilepsy Center discussed the currently known overlap between neurological diseases and the need to identify causative biomarkers. [WATCH TIME: 4 minutes]
February 10, 2022
Video
The director of Cleveland Clinic’s Epilepsy Center provided insight on a new 20-year initiative to uncover more about the origins of neurological diseases and how they occur prior to symptom onset. [WATCH TIME: 3 minutes]
December 15, 2021
Video
The director of the epilepsy center at Cleveland Clinic Neurological Institute spoke on one of the studies he coauthored that were presented at AES 2021. [WATCH TIME: 4 minutes]
December 14, 2021
Video
The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute discussed the need for specificity and artificial intelligence for patients with epilepsy. [WATCH TIME: 4 minutes]
December 10, 2021
Video
The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute spoke on the latest advances with epilepsy surgery, as well as what still needs to be learned. [WATCH TIME: 5 minutes]
December 09, 2021
Video
The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute discussed poignant presentations from the 2021 American Epilepsy Society Annual Meeting. [WATCH TIME: 7 minutes]
June 03, 2021
Video
An overview of available treatment options in epilepsy treatment to increase patient compliance, and a deeper diver into the recent data from the phase 4 ELEVATE study of perampanel.
May 27, 2021
Video
An expert neurologist outlines best practices to consider in epilepsy therapy to increase patient compliance.
May 27, 2021
Video
A discussion about the impact of coronavirus 2019 (COVID-19) on patient compliance with epilepsy therapy.
AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant
NeurologyLive® Friday 5 — May 27, 2022
Neurology on the Hill 2022: Takeaways and Progress
Erenumab Shows Effectiveness as Migraine Preventive in Those With Prior Treatment Failures